Ferheen Baig is a skilled analytical scientist with extensive experience in research and development within the pharmaceutical industry and academia. Currently serving as a Medical Science Liaison in Cardiology at Amarin Corporation since January 2022, Ferheen conducts research focused on vascular remodeling of extracellular matrix proteins in Cardiovascular Disease and Type 2 Diabetes. Previous roles include serving as a Cardiovascular Proteomics PhD researcher at King's College London from June 2014 to December 2021, and holding positions as a Protein & Biomarker Bioanalyst at Novartis Institutes for BioMedical Research and a DMPK Bioanalyst at GSK. Educational credentials include a PhD in Cardiovascular Proteomics and an MSc in Forensic Science, alongside a BSc in Biomedical Science from reputable institutions in London.
This person is not in any teams
This person is not in any offices